Brind.
  1. Alligator Bioscience is identified as a clinical-stage biotechnology company.

Alligator Bioscience Establishes Nomination Committee for 2027 AGM

1 report, 1 independent Updated Nov 3
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Alligator Bioscience established its Nomination Committee in preparation for the Annual General Meeting on May 6, 2027. The committee was formed based on the company's largest shareholders as of October 19, 2026, due to the effects of a recent rights issue. The committee currently consists of three members, representing approximately 3.28 percent of the shares and votes.

From pr-inside.com

Why it matters

Some supportBrind's analysis of the reports

The committee is responsible for preparing for the Annual General Meeting, which involves the selection of board members. The structure of the committee reflects the voting rights of the three largest shareholders and the Chairman of the Board.

Alligator Bioscience is a clinical-stage biotechnology company.

From pr-inside.com

Who's involved

  • Lars BergkvistLars Bergkvist is part of the Nomination Committee established for the AGM 2027.

Keep exploring

Coverage

Newest first; wire copies grouped